Zicam Products, Fleet Enemas, and More

Recording Date: December 9, 2009
Duration: 103 minutes

Didn’t Attend?

120909 OTC Drug Litigation

Purchase the
Teleconference
Audio Package $149

Purchase the Teleconference Audio Package (includes MP3 files and handbook on CD). To order or learn more, click here or contact Allison Emery at 484-324-2755 x205 or allison.emery@litigationconferences.com.

Attendees get the teleconference Audio Package for 50% off!

Agenda and Speakers

Zicam Products, Fleet Enemas, and More

  • Strategies for client screening and ensuring your case has evidentiary support
  • Understanding the differences between prescribed and over the counter (OTC) drug litigations
  • The FDA’s role in regulating over the counter drugs-is it effective, what can be improved and how to achieve this
  • Recent OTC litigations:
    • Important Considerations for Evaluating Zicam Cases
      • What drugs are covered by the FDA’s recent recall and their market penetration
      • Long term and short term side effects of the suspect Zicam products – Anosmia, loss of taste, depression, malnutrition, and others
      • How to screen your clients in a Zicam case
      • What kind of evidence will you need?
      • The kind of medical experts and reports you will need for your case
      • The score board: what kind of settlements have been reached, the status of class actions, and the financial prospects of Matrixx in light of the recall
      • Making the decision to settle or try your Zicam case
      • The FDA’s role in reviewing homeopathic drugs like Matrixx’ Zicam
    • Fleet
      • Enemas – what brands are causing injury? What about generics?
      • Long term and short term injuries to the kidneys
      • Course of treatment and likely success
      • The number of lawsuits, where they are being filed and the potential damages
      • How to value a claim

Faculty:
Hirlye R. “Ryan” Lutz, III, Esq., Cory Watson Crowder & DeGaris, Birmingham
Stacy Hauer, Esq., Zimmerman Reed, Minneapolis